Management Team

Neurolixis benefits from a management team with many decades of cumulative industrial and academic experience. The members of the team bring drug discovery, neuropharmacology, clinical research and company management expertise to Neurolixis.

Adrian Newman-Tancredi, PhD, DSc Co-founder, President and CEO

Dr. Newman-Tancredi has broad expertise in neuroscience drug discovery and early pre-clinical development. He was previously Director of Neurobiology and Project Manager at Pierre Fabre Laboratories. More...

Steven A. Johnson, PhD, Vice-President, Drug Development

Dr. Johnson has extensive experience of pre-clinical and clinical drug development in neurobiology and neuropsychiatry. He was previously Vice-President and Executive Officer at Cortex Pharmaceuticals. More...

Ronan Depoortere, PhD, Director Pharmacology

Dr. Depoortere is a highly experienced pharmacologist and participated in the characterization of antipsychotics and antidepressants. He was previously Senior Scientist at Sanofi and Synthelabo. More...

Mark A. Varney, PhD, Co-founder, Director

Dr. Varney has spent over two decades in pharmaceutical research and was previously Chief Executive Officer of Cortex Pharmaceuticals, and Vice-President and Head of Discovery at Sepracor (now Sunovion). More...